Yurdacan, B. Et Al. 2019. Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid. JOURNAL OF PHARMACY AND PHARMACOLOGY , vol.71, no.7 , 1119-1132.

Yurdacan, B., Egeli, Ü., Eskiler, G. G., Eryılmaz, I. E., Çeçener, G., & Tunca, B., (2019). Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid. JOURNAL OF PHARMACY AND PHARMACOLOGY , vol.71, no.7, 1119-1132.

Yurdacan, Beste Et Al. "Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid," JOURNAL OF PHARMACY AND PHARMACOLOGY , vol.71, no.7, 1119-1132, 2019

Yurdacan, Beste Et Al. "Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid." JOURNAL OF PHARMACY AND PHARMACOLOGY , vol.71, no.7, pp.1119-1132, 2019

Yurdacan, B. Et Al. (2019) . "Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid." JOURNAL OF PHARMACY AND PHARMACOLOGY , vol.71, no.7, pp.1119-1132.

@article{article, author={Beste Yurdacan Et Al. }, title={Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid}, journal={JOURNAL OF PHARMACY AND PHARMACOLOGY}, year=2019, pages={1119-1132} }